— Harbour is disrupting and growing trillion-dollar industries in Pharma, Food & Beverage, Nutraceuticals, and sustainable agricultural fertilizer as the only Canadian coca leaf importer and processor
The coca leaf has been used by illegal organizations to make billions in profit by selling the illicit byproduct – cocaine .
The coca leaf has been used by illegal organizations to make billionsin profit by selling the illicit byproduct – cocaine. Hollywood has romanticized the whole picture with violent and equally opulent lifestyles of the purveyors of this highly profi table byproduct of the cocoa leaf.
Look closer …
The coca plant is a super plant with a host of legal applicationsready to be commercialized worldwide.
The coca plant is a super plant with a host of legal applications ready to be commercialized worldwide.
Harbour transforms multiple industries with innovative applications of exclusive coca-leaf importation and processing
The only Canadian company to partner with government agencies in Canada to both import and process coca leaf for consumer, pharmaceutical and Industrial use. The opportunity to create entirely new categories and value for the use of coca leaf products across multiple industries. Blue-chip collaborations with both pharma and consumer good companies.
The ability to tap directly into burgeoning global fertilizer market Ina sustainable manner.
How Coca Leaf’s Vast Potential Has Remained Untapped and Left Investors Behind
Until now, one U.S. company has monopolized the legal coca leaf importation and processing for the past 130 years
Coca-Cola has in revenue using the legal fla vor extract found in the coca leaf
Until now, one U.S. company has monopolized the legal coca leaf importation and processing for the past 130 years
Harbour is Disrupting the Coca Leaf Monopoly and Unleashing its Extensive Potential
Harbour is introducing coca leaf pharmaceutical ingredients, flavor components, and bio-functional compounds on a global scal
Through groundbreaking agreementswith the Canadian (national, provincial, and city) governments and the SouthAmerican Peruvian coca authority, Harbour hassuccessfully secured the ability to import an unrestricted volume of coca derivatives into Canada for processing and application across various industries
With numerous strategic partnerships, Harbour presents an innovative approach that allowsinvestors to tap into the wide range of opportunities presented by this exceptional plant
With numerous strategicFrom nutraceutical and cosmetic production to soil revitalization through fertilization and collaborative venturesspanning multiple industries, Harbour's trailblazing strides are on the verge of unleashing the complete potential of the coca leaf. partnerships, Harbour presents an innovative approach that allowsinvestors to tap into the wide range of opportunities presented by this exceptional plant
Harbour.
Capitalizing a once in a generation
opportunity and disrupting numerous
multi-billion industries
Harbour is launching into three main verticals :
API (Active Pharmaceutical Ingredients) for Pharma is an existing $344 billion market and growing. Harbour has a plan to sell API to Pharma in Canada and globally for:
Diet & Weight Loss
ADHD Medication
Local Anesthetics
Anti-Inflammatory Medications
Vasoconstriction in Capillaries
Harbour will also process non-active ingredients for multiple verticals in a combined $1 trillion market. Coca is an x-factor super plant that offers a host of bio-functional benefits with no psychoactive effects.
Beverages & Teas
Protein Powders
Local Anesthetics
Nutraceuticals & Supplements
Cosmetics & Skincare
Colognes & Perfumes
High Yield Fertilizers for Commercial Agriculture
Beverages & Teas
Protein Powders
Local Anesthetics
Nutraceuticals & Supplements
Cosmetics & Skincare
Colognes & Perfumes
High Yield Fertilizers for Commercial Agriculture
Harbour is disrupting numerous multi-billion dollar industries by capitalizing on a once-in-a-generation opportunity.
In current discussions with several established CPG brands across North America.
Harbour signed a historic agreement with a legal state-owned coca leaf producer with 35,000 registered farms.
API’s: 20x ROI
Extracts: ~80%
Fertilizer: ~50-60%
Our supplier is also a manufacturer that provides the option to co-pack immediately.
Our executive management and advisory team has over 50 years of regulatory, CPG, capital and public market experience with C level executives running $600 million + value corporations.
Active pharmaceutical ingredients: $344 billion market
Established CPG brand ingredients and direct CPG brands: 1 $Trillion market
Fertilizer ingredients: $200 billion market.
Harbour has a public listing planned by RTO Q1 2024.
Trade agreement: Harbour has signed an exclusive trade agreement, enabling us to import an unlimited supply of coca leaf derivatives into Canada for extra ction and production .
Health Canada license: AHealth Canada license, anticipated to be issued in November 2023, will grant Harbour the authority to import, process, and sell c ontrolled coca leaf products within Canada and for global export. Our licensing consultant has ensured the guarantee of this license .
Government support: Collaborating with Latin American state-run coca leaf suppliers, Canadian municipalities, government legislators, law en force met, Health Canada, The Canadian Food Inspection Agency, and the Canadian Border Security Agency, Harbour is establishing a completely Canadian source for legal coca leaf derivative inputs to Canadian businesses.
Blue chip customer opportunities: With innovative products and ingredients, Harbour is engaged in discussions with several blue chip consumer brands eager for collaboration. A Letter of Intent (LOI) for $100,000 USD has been signed.
Certified processor,GMP facility: Harbour possesses access to custom proprietary equipment, designed to ensure secure and fully Health Canada compliant ext raction of active and non – active compounds. The utilization of existing GMP certified faci lities empowers Harbour to swiftly adapt and meet the requirements outlined by Health Cana da regulators for handling, processing, packaging, labeling, and inventory tracking .
A Coca Leaf Super Plant Supplement Line
For Use In Bulk Orders
A Coca Leaf Plant Protein Full of the Coca Leaf Super Powers
The Super Power of Coca Leaf In A Sipable Tea
Six big reasons to Invest in Company
DiExclusive government contracts with Country Authorities.
Guaranteed legal supply through signed 5 year renewable agreement with major supplier .
Short path to commercialization (partners have 70 years of commercialization experience )
Over 1400 consumer applications
Experienced executive team with public market experience and running over $600 million in corporate value
Sustainable practices and support of minority communities
Fast go public IPO strategy
Harbour has strong traction. Great business fundamentals. An experienced team. A strong balance sheet. Consistent disruptive announcements. Harbornbrings forth a strong value creation strategy designednto deliver the best returns to all stakeholders
CEO
"Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor.
CEO
"Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor.
Equity
Reg D 506C
$0.52 USD
$3M
$5,000
Pre-IPO
Limited round access. Have questions ?
Call 917-997-4911
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem dolore, alias, numquam enim ab voluptate id quam harum ducimus cupiditate similique quisquam et deserunt, recusandae.
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem dolore, alias, numquam enim ab voluptate id quam harum ducimus cupiditate similique quisquam et deserunt, recusandae.
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem dolore, alias, numquam enim ab voluptate id quam harum ducimus cupiditate similique quisquam et deserunt, recusandae.
$5,000
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem dolore, alias, numquam enim ab voluptate id quam harum ducimus cupiditate similique quisquam et deserunt, recusandae.
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem dolore, alias, numquam enim ab voluptate id quam harum ducimus cupiditate similique quisquam et deserunt, recusandae.
Once shares are purchased, and your investment is approved, we will be issuing your shares within X days.
These are not free-trading shares. The roadmap for Company is toward an IPO at which point the shares will convert into publicly traded shares. Initial restrictions on sales may apply. What are the tax implications of investing in Company Solution? The tax implications of investing in Company Solution will depend on your individual circumstances. You should consult with a tax advisor to determine the tax implications for you.
info@company.com
xxx-xxx-xxxx
Address 21468, Zip 908665
Forward-Looking StatementsCertain information set forth in this website contains “forward-looking information”, including “future-oriented financial information” and “financial outlook”, under applicable securities laws (collectively referred to herein as forward-looking statements). Except for statements of historical fact, the information contained herein constitutes forward-looking statements and includes, but is not limited to, the (i) projected financial performance of the Company; (ii) completion of, and the use of proceeds from, the sale of the shares being offered hereunder; (iii) the expected development of the Company’s business, projects, and joint ventures; (iv) execution of the Company’s vision and growth strategy, including with respect to future M&A activity and global growth; (v) sources and availability of third-party financing for the Company’s projects; (vi) completion of the Company’s projects that are currently underway, in development or otherwise under consideration; (vi) renewal of the Company’s current customer, supplier and other material agreements; and (vii) future liquidity, working capital, and capital requirements. Forward-looking statements are provided to allow potential investors the opportunity to understand management’s beliefs and opinions in respect of the future so that they may use such beliefs and opinions as one factor in evaluating an investment.These statements are not guarantees of future performance and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or result expressed or implied by such forward-looking statements.Although forward-looking statements contained in this website are based upon what management of the Company believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements if circumstances or management’s estimates or opinions should change except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements.
Link #1 Lorem ipsum dolor sit amet, consectet
Link #1 Lorem ipsum dolor sit amet, consectet
Link #1 Lorem ipsum dolor sit amet, consectet
Link #1 Lorem ipsum dolor sit amet, consectet
Link #1 Lorem ipsum dolor sit amet, consectet
Link #1 Lorem ipsum dolor sit amet, consectet
Link #1 Lorem ipsum dolor sit amet, consectet
Link #1 Lorem ipsum dolor sit amet, consectet